Research Library
Curated Studies & Clinical Data
A growing library of peer-reviewed studies, clinical trial data, and systematic reviews organized by compound. Every citation is linked to its primary source.
Tirzepatide for pasireotide-induced hyperglycemia in a GH/TSH-producing pituitary adenoma/PitNET: a case report and literature review
Endocrine journal, 2026
Improvement of small fiber neuropathy assessed by corneal confocal microscopy following semaglutide treatment: a case report and literature review
Hormones (Athens, Greece), 2026
Assessing the Association Between GLP-1 Receptor Agonists and Diabetic Foot Complications Using Real-World Pharmacovigilance Database and Mendelian Randomization
The international journal of lower extremity wounds, 2026;:15347346261487722
International expert panel review for the use of resmetirom and semaglutide in the management of MASH-related fibrosis: clinical practice update
Gut, 2026
Structural Overview of GLP-1 Analogs
Biomedical journal, 2026;:101037
Where the Future Lies: GLP-1 Receptor Agonists as Therapeutics for Dermatologic Comorbidities
Clinics in dermatology, 2026
Metabolic Effects of a GLP-1 Analog Combined with Aerobic Training in Ovariectomized Rats
Molecular and cellular endocrinology, 2026;:112917
Postoperative outcomes after total knee arthroplasty in type 2 diabetes mellitus patients receiving semaglutide versus tirzepatide: a propensity score-matched national research network analysis
The Knee, 2026;63:104639
The Expanding Role of GLP-1 Receptor Agonists and Dual GIP/GLP-1 Agonists in Dermatology: From Immunometabolism to Clinical Practice
Dermatology and therapy, 2026
Combination of genetic eNOS deficiency and high-fat diet induces reproducible cardiometabolic HFpEF
Redox biology, 2026;97:104394
Assessing the quality and reliability of health information on GLP-1 receptor agonists on TikTok and Bilibili: a cross-sectional analysis of the public health infodemic
Therapeutic advances in endocrinology and metabolism, 2026;17:20420188261467887
The Impact of Glucagon-Like Peptide-1 Receptor Agonist-Induced Nutritional Deficiencies on Skin Health: A Narrative Review With a Proposed Framework for the Aesthetic Practitioner
Aesthetic surgery journal. Open forum, 2026;8:ojag169
Reduced Risk in Melanoma and Nonmelanoma Skin Cancers in Obese Patients on Semaglutide and Tirzepatide
Dermatologic surgery : official publication for American Society for Dermatologic Surgery [et al.], 2026
GLP-1 receptor agonism in Alzheimer’s disease after EVOKE: From single hypothesis to stratified program
Journal of Alzheimer's disease : JAD, 2026;:13872877261485580
Comparative outcomes for tirzepatide versus glucagon-like peptide-1 receptor agonists in patients with inflammatory bowel disease: a national propensity matched study
Intestinal research, 2026
Carbon Emission Impact of Semaglutide in People with Obesity in the UK Using a Disease Modelling Approach
PharmacoEconomics, 2026
Wegovy: GPs are told not to prescribe GLP semaglutide for heart health without funding guarantee
BMJ (Clinical research ed.), 2026;394:e100816
Increased Energy Expenditure through Intermittent Cold Exposure Does Not Enhance Tirzepatide Induced Weight-loss in Obese Mice
American journal of physiology. Regulatory, integrative and comparative physiology, 2026
Tirzepatide and oral progestogens: A hypothesis-generating review of a biologically plausible pharmacokinetic interaction in gynaecologic disease control and menopausal hormone therapy
Maturitas, 2026;214:109116
CARDIOVASCULAR EFFECTS OF INCRETIN RECEPTOR AGONISTS: BEYOND GLYCEMIC CONTROL
Canadian journal of physiology and pharmacology, 2026